Sources | Names Used |
---|---|
CTRPv2 | KU 0060648 |
PharmacoGx | KU 0060648 |
Database | Identifier |
---|---|
Smiles: | CCN1CCN(CC(=O)Nc2ccc(-c3cccc4c3oc(cc4=O)N3CCOCC3)c3sc4ccccc4c23)CC1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HPS4 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
mRNA | CDC40 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
mRNA | CD80 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
mRNA | SLX4IP | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
mRNA | ARHGAP21 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
mRNA | FOXD4 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
mRNA | RP11-101E3.5 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
mRNA | CRYBB1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
mRNA | HDAC9 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
mRNA | FMO1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |